The three patients carrying the novel mutations (P2, P5 and P9) had the clinical and immunologic features of STAT3 deficiency even though we did not perform functional experiments for those new mutation sites. The gene discussed is STAT3; the disease is hyperinsulinemic hypoglycemia, familial, 4.